Ligand validation:8SKO

X8Z: L-CAPTOPRIL

X8Z is a Ligand Of Interest in 8SKO designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8SKO_X8Z_A_303	65%	51%	0.133	0.935	0.74	1.13	-	-	4	0	100%	0.8
8SKO_X8Z_B_303	63%	54%	0.15	0.946	0.6	1.18	-	2	1	0	100%	0.8
5ZIO_X8Z_A_303	76%	57%	0.138	0.976	0.76	0.91	-	-	0	0	100%	1
4EXS_X8Z_A_301	54%	48%	0.153	0.919	0.58	1.4	-	2	2	0	100%	1
2X8Z_X8Z_A_1615	82%	36%	0.111	0.966	1.32	1.22	2	1	0	0	100%	1
4C1H_X8Z_A_305	76%	17%	0.129	0.966	2.19	1.41	3	2	0	0	100%	0.7
4PQA_X8Z_A_401	75%	55%	0.117	0.95	0.64	1.07	-	1	1	0	100%	1
4DPR_X8Z_A_702	67%	21%	0.14	0.949	2.07	1.25	3	4	3	0	100%	1
4C1D_X8Z_A_350	65%	17%	0.157	0.961	2.14	1.46	4	5	0	0	100%	0.8

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.